Hypertension Trial, Recruiting (NCT06730230)

Hypertension Trial, Recruiting NCT06730230 Sponsor: NYU Langone Health Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06730230 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who identify as Latinx
People who are fluent in English or Spanish
People who are 18 years of age or older
People who receive care at one of the 10 participating safety-net primary care clinics
People whose medical records show high blood pressure readings (average of 140/90 mmHg or higher) at two or more clinic visits in the past year
People who have been prescribed at least one blood pressure-lowering medication but whose records show they have been taking it less than 80% of the time over the past 12 months

Who may not be able to join:

People who are unable or unwilling to complete all tasks required by the study
People who are currently participating in another clinical trial related to high blood pressure
People whose medical records document a significant mental health condition or substance use issue
People who plan to stop receiving care at the clinic within the next 15 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Devin Mann, MD, NYU Langone Health

Phone: 212-263-8313

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06730230

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: 212-263-8313

More information: https://clinicaltrials.gov/study/NCT06730230

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who identify as Latinx
People who are fluent in English or Spanish
People who are 18 years of age or older
People who receive care at one of the 10 participating safety-net primary care clinics
People whose medical records show high blood pressure readings (average of 140/90 mmHg or higher) at two or more clinic visits in the past year
People who have been prescribed at least one blood pressure-lowering medication but whose records show they have been taking it less than 80% of the time over the past 12 months

Who may not be able to join:

People who are unable or unwilling to complete all tasks required by the study
People who are currently participating in another clinical trial related to high blood pressure
People whose medical records document a significant mental health condition or substance use issue
People who plan to stop receiving care at the clinic within the next 15 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

10 February 2025

Est. completion

31 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in systolic blood pressure; Change in diastolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov